Three important findings have emerged from recent research on COVID-19. First, long COVID -- the persistence of symptoms after the acute infection -- is common and can cause significant suffering and disability. Second, the ability of the bivalent booster to broaden recipients' immune response and reduce the frequency of hospitalizations and deaths has exceeded expectations. Third, the data argue for an intensive effort to convince more Americans to get the bivalent booster and to wear masks in moderate- and high-risk situations.
Read Full Article »
